WAM Clothes Mall
Get Hot Sale for Clothes
    • Home
    • Policies
    • Blog Updates
    • Contact Us

    About

    The styles combine with shapes and produce the best landscape for every single celebration; With years in the style refinement globe, we have acquired the excellent creative overview outfits. We have actually become the incredible allied brand prolonging the glamor you are entitled to because by sharing a common objective: to make every moment the best circumstances to use stunning gowns.

    Recent Posts

    • CBD Supply Seen Diminishing as Farmers Flee Hemp: Cannabis Weekly
      August 11, 2020
    • Now we’re, where?: Canopy, Drake joint venture not progressing ‘as desired’Now we’re, where?: Canopy, Drake joint venture not progressing ‘as desired’
      August 10, 2020
    • Strong medical pot sales assist Canopy Development beat Q1 expectationsStrong medical pot sales assist Canopy Development beat Q1 expectations
      August 10, 2020
    GW Pharma Reports Q4 Earnings, Beats Revenue Target

    GW Pharma Reports Q4 Earnings, Beats Revenue Target

    Click here for The Motley Fool’s resources on Coronavirus and the market. Sales of its CBD-derived epilepsy drug continue to surge. GW Pharmaceuticals (NASDAQ:GWPH) announced its fourth quarter and full year financial results Tuesday afternoon. Although the company ended up missing the earnings target set by Wall Street, GW Pharma did manage to handily beat…

    Click here for The Motley Fool’s resources on Coronavirus and the market.

    Sales of its CBD-derived epilepsy drug continue to surge.

    Mark Prvulovic

    GW Pharmaceuticals (NASDAQ:GWPH) announced its fourth quarter and full year financial results Tuesday afternoon. Although the company ended up missing the earnings target set by Wall Street, GW Pharma did manage to handily beat analysts’ revenue expectations for the company.

    Fourth quarter revenue came in at $109.1 million, a drastic increase from the $6.6 million reported a year ago. The vast majority of this figure came from sales of its CBD-derived drug, Epidiolex, which is used to treat two rare types of epilepsy in children known as Lennox-Gastaut syndrome and Dravet syndrome. The pharmaceutical company said that it sold $104.5 million worth of Epidiolex in the fourth quarter.

    A close-up of a cannabis plant.

    Image source: Getty Images.

    GW Pharma also reported a fourth quarter 2019 net loss of $24.9 million, which is a significant improvement from the $71.9 million net loss seen in fourth quarter 2018. The company still has $536.9 million in cash and cash equivalents as well, more than enough to fund itself as it looks to break a profit in 2020.

    Further details

    Although GW Pharma ended up missing its earnings target, reporting a net loss per share of $0.07 in comparison to the net loss per share of $0.04 expected by analysts, revenue figures were well received. Wall Street had predicted around $105.1 million in sales for the quarter, a figure the company handily beat by $4 million.

    Epidiolex holds the distinction of being the first CBD-derived drug to receive approval from the U.S. Food and Drug Administration. The decision, which was announced in June 2018, was a big deal for the industry, although the agency has yet to approve another cannabis drug since then.


    Mark Prvulovic has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.”>

    CBD Oil, Cannabinoid On A Budget: 9 Tips From The Great Depression
    Read More

    Chipsteaks are distinct and scrumptious, with incredible protein value Why Charlotte’s Web Holdings Stock Is Plunging Today
    Health

    CBD Supply Seen Diminishing as Farmers Flee Hemp: Cannabis Weekly

    Now we’re, where?: Canopy, Drake joint venture not progressing ‘as desired’
    Health

    Now we’re, where?: Canopy, Drake joint venture not progressing ‘as desired’

    Strong medical pot sales assist Canopy Development beat Q1 expectations
    Health

    Strong medical pot sales assist Canopy Development beat Q1 expectations

    © WAM Clothes Mall 2022